Frost Mark T
Harvard Bioscience, Inc. · Chief Financial Officer
Frost Mark T is listed in filings as Chief Financial Officer at Harvard Bioscience, Inc.. This profile follows SEC Form 4 activity through Apr 1, 2026, including purchase activity. Recent filings connect the profile to Harvard Bioscience, Inc. (HBIO). The current snapshot covers public activity from May 14, 2025 to Apr 1, 2026. Reported amounts are shown as $25.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $25k5k shares | BuyMar 16, 2026 | $5.00 | $6.23 |